Chronic inflammation and cancer: Emerging roles of triggering receptors expressed on myeloid cells

Expert Review of Clinical Immunology

Volumn 11, Issue 7, 2015, Pages 849-857

  Nguyen, Austin Huy ^a   Berim, Ilya G ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic inflammation; colorectal cancer; hepatocellular carcinoma; inflammatory bowel disease; leukemia; neoplastic disease; non small cell lung cancer; TREM 1; TREM 2; triggering receptor expressed on myeloid cells

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; CELL SURFACE RECEPTOR; TUMOR PROTEIN;

BONE MARROW CELL; CARCINOGENESIS; CHRONIC INFLAMMATION; COLITIS; COLORECTAL CANCER; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS; HUMAN; INNATE IMMUNITY; LEUKEMIA; LUNG DISEASE; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MICROGLIA; NEOPLASM; OSTEOCLAST; REVIEW; ANIMAL; CELL TRANSFORMATION; CHRONIC DISEASE; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; MYELOID CELLS; NEOPLASM PROTEINS; NEOPLASMS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84932122117     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2015.1043893     Document Type: Review

References (69)

1. Allcock RJN, Barrow AD, Forbes S, et al. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 2003;33: 567-77
2. Arts RJW, Joosten L a B, van der Meer JWM, et al. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol 2013;93:209-15
3. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008;213:701-13
4. Bouchon A, Dietrich J, Colonna M. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes. J Immunol 2000;164:4991-5
5. Bouchon A, Hernández-munain C, Cella M, et al. A DAP12-mediated Pathway Regulates Expression of CC Chemokine Receptor 7 and Maturation of Human Dendritic Cells. J Exp Med 2001;194:1111-22
6. Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009;227:150-60
7. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol 2003;3: 445-53
8. Colonna M, Facchetti F. TREM-1 (Triggering Receptor Expressed on Myeloid Cells) : A New Player in Acute Inflammatory Responses. J Infect Dis 2003;1:397-401
9. Bleharski JR, Kiessler V, Buonsanti C, et al. A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response. J Immunol 2003;170:3812-18
10. Pelham C, Agrawal D. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Rev Clin Immunol 2014;10:243-56
11. Pelham CJ, Pandya AN, Agrawal DK. Triggering receptor expressed on myeloid cells receptor family modulators: a patent review. Expert Opin Ther Pat 2014;24: 1383-95
12. Haselmayer P. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007;110:1029-36
13. Wong-Baeza I, González-Roldán N, Ferat-Osorio E, et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 2006;145: 448-55
14. Wu J, Li J, Salcedo R, et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res 2012;72:3977-86
15. Read CB, Kuijper JL, Hjorth SA, et al. Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1. J Immunol 2015;194:1417-21
16. Daws MR, Sullam PM, Niemi EC, et al. Pattern Recognition by TREM-2: Binding of Anionic Ligands. J Immunol 2014;171: 594-9
17. N'Diaye E-N, Branda CS, Branda SS, et al. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J Cell Biol 2009;184:215-23
18. Turnbull IR, Gilfillan S, Cella M, et al. Cutting Edge: TREM-2 Attenuates Macrophage Activation. J Immunol 2006;177:3520-4
19. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011; 105(Suppl):S13-33
20. Washington AV, Schubert RL, Quigley L, et al. A TREM family member, TLT-1, is found exclusively in the a-granules of megakaryocytes and platelets. Blood 2004;104:1042-8
21. Washington AV, Gibot S, Acevedo I, et al. TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest 2009;119:1489-501
22. Derive M, Bouazza Y, Sennoun N, et al. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol 2012;188:5585-92
23. Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009;21:38-46
24. Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81
25. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-44
26. Liao R, Sun T-W, Yi Y, et al. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Sci 2012;103:984-92
27. Ho C-C, Liao W-Y, Wang C-Y, et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 2008;177:763-70
28. Zhu W, Fang C, Gramatikoff K, et al. Proteins and an inflammatory network expresed in colon tumors. J Proteome Res 2012;10:2129-39
29. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012;3:107
30. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34
31. Schenk M, Bouchon A, Birrer S, et al. Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine. J Immunol 2004;174:517-24
32. Schenk M, Bouchon A, Seibold F, et al. TREM-1 - expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007;117:3097-106
33. Billioud V, Gibot S, Massin F, et al. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease. Dig Liver Dis 2012;44:466-70
34. Park JJ, Cheon JH, Kim BY, et al. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci 2009;54:1525-31
35. Saurer L, Rihs S, Birrer M, et al. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity. J Crohns Colitis 2012;6: 913-23
36. Tzivras M, Koussoulas V, Giamarellos-Bourboulis E, et al. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. World J Gastroenterol 2006;12:3416-19
37. Jung YS, Park JJ, Kim SW, et al. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases. Dig Liver Dis 2012;44:897-903
38. Correale C, Genua M, Vetrano S, et al. Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response. Gastroenterology 2013;144:346-56; e3
39. Zhou J, Chai F, Lu G, et al. TREM-1 inhibition attenuates inflammation and tumor within the colon. Int Immunopharmacol 2013;17:155-61
40. Rigo I, McMahon L, Dhawan P, et al. Induction of triggering receptor expressed on myeloid cells (TREM-1) in airway epithelial cells by 1,25(OH)2 vitamin D3. Innate Immunol 2012;18:250-7
41. Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer 2012;131:2724-32
42. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004;567:447-74
43. Woodruff PG, Ellwanger A, Solon M, et al. Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice. COPD 2009;6:86-94
44. Gan WQ. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80
45. Radsak MP, Taube C, Haselmayer P, et al. Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007:2007:52040
46. Nichols D, Chmiel J, Berger M. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin Rev Allergy Immunol 2008;34:146-62
47. Maisonneuve P, Marshall BC, Knapp EA, et al. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 2013;105:122-9
48. Del Fresno C, García-Rio F, Gómez-Piña V, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009;182:6494-507
49. Gomez-Pina V. Soares-Schanoski a., Rodriguez-Rojas a., et al. Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human Monocytes. J Immunol 2007;179:4065-73
50. Li C, Li H, Jiang K, et al. TLR4 signaling pathway in mouse Lewis lung cancer cells promotes the expression of TGF-β1 and IL-10 and tumor cells migration. Biomed Mater Eng 2014;24:869-75
51. Yuan Z, Mehta HJ, Mohammed K, et al. TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer. PLoS One 2014;9:e94241
52. Karapanagiotou EM, Pelekanou E, Charpidou A, et al. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. Anticancer Res 2008;28:1411-15
53. Sigalov AB. A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock. Int Immunopharmacol 2014;21: 208-19
54. Nochi H, Aoki N, Oikawa K, et al. Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. Am J Pathol 2003;162:1191-201
55. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Lett to Nat 2004;431:461-6
56. Maeda S, Kamata H, Luo J-L, et al. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977-90
57. Sakurai T, Maeda S, Chang L, et al. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A 2006;103:10544-51
58. Schulz A, Toedt G, Zenz T, et al. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2. Haematologica 2011;96:408-16
59. Li W, Yi X, Huang S, et al. Differential expression of TREM-1 In myelogenous leukemia cells. Li Li HJ, ed Blood 2013;122:4951
60. Klein G, Vellenga E, Fraaije MW, et al. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 2004;50:87-100
61. Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010;28:367-88
62. Klesney-tait J, Keck K, Li X, et al. Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest 2013;123:138-49
63. Seno H, Miyoshi H, Brown SL, et al. Efficient colonic mucosal wound repair requires Trem2 signaling. Proc Natl Acad Sci 2008;106:256-61
64. Nguyen AH, Berim IG, Agrawal DK. Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol 2014;10:1711-30
65. Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol 2012;167:195-205
66. Ye W, Hu Y, Zhang R, et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in lower respiratory tract infections: a meta-analysis. Respirology 2014;19:501-7
67. Summah H, Tao L-L, Zhu Y-G, et al. Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis. BMC Infect Dis 2011;11:280
68. Zhang J, She D, Feng D, et al. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infect Dis 2011;11:53
69. Su L, Han B, Liu C, et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 2012;12:157